Oura postponed its Nasdaq IPO in the week it was slated to list, while reporting a profit and projecting 90% revenue growth for fiscal 2026. Bloomberg ties a run of delayed deals to a market waiting on Anthropic, so the test for Oura is whether it comes back on the same terms after that listing.
Perspective Coverage
16 publishers
- Builder
- Builder 10%
- Operator
- Operator 20%
- Investor
- Investor 70%
Reality
- Evidence72
- Adoption55
- Hype gap+35
- Incentives68
- Confidence68
Oura postpones a $15.6 billion IPO that would have paid selling shareholders 73% of the cash
Oura has postponed an IPO that valued it at up to $15.6 billion, with existing holders selling 73% of the shares on offer. To pay that price, public buyers had to see an AI health platform in a company whose sales still lean on a ring.
Reality
- Evidence55
- Adoption
- Not scored
- Hype gap+20
- Incentives65
- Confidence55
Oura postponed its $2.2bn Nasdaq IPO on pricing day after its shares reportedly looked set to sell at the bottom of their $40-to-$44 range. Even $40 a share would have valued the profitable ring maker near $14.2bn, above its 2025 private round, so the dispute is over how far above.
Perspective Coverage
4 publishers
- Builder
- Builder 9%
- Operator
- Operator 17%
- Investor
- Investor 74%
Reality
- Evidence68
- Adoption50
- Hype gap+25
- Incentives60
- Confidence62
Existing holders are selling 36.5 million of the 50 million shares on offer. Oura's own 13.5 million would net about $532.6 million at the $42 midpoint, ahead of pricing on September 29 at up to $14.1 billion.
Perspective Coverage
5 publishers
- Builder
- Builder 19%
- Operator
- Operator 22%
- Investor
- Investor 59%
Reality
- Evidence72
- Adoption78
- Hype gap+18
- Incentives76
- Confidence68
Oura's $3B IPO asks $16B for a business where four fifths of revenue is still hardware
The 45% markup in eleven months is measured off October's $11B round. Membership at $5.99 covers roughly a fifth of forecast 2026 sales, and the draft filing carries no audited numbers.
Reality
- Evidence34
- Adoption62
- Hype gap+38
- Incentives72
- Confidence40